Emulate Revenue and Competitors
Estimated Revenue & Valuation
- Emulate's estimated annual revenue is currently $32.5M per year.
- Emulate received $36.0M in venture funding in June 2018.
- Emulate's estimated revenue per employee is $193,750
- Emulate's total funding is $224.3M.
Employee Data
- Emulate has 168 Employees.
- Emulate grew their employee count by 4% last year.
Emulate's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, CTO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP, Platform Development | Reveal Email/Phone |
4 | Senior Director, Applied BioScience | Reveal Email/Phone |
5 | Director Commercial Operations | Reveal Email/Phone |
6 | Associate Director Product Management | Reveal Email/Phone |
7 | Associate Director Quality Assurance | Reveal Email/Phone |
8 | Director Lab Operations | Reveal Email/Phone |
9 | Associate Director, Applied BioSciences | Reveal Email/Phone |
10 | Director, Discovery Biology | Reveal Email/Phone |
Emulate Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $14.3M | 59 | -6% | N/A | N/A |
#2 | $26.4M | 178 | -28% | N/A | N/A |
What Is Emulate?
We work at the intersection of biology, engineering, and design, developing technologies that emulate human biology. Our products are enabling a new era of precision medicine and the development of applications for personalized health. Our Human Emulation System, which uses Organs-on-Chips technology, is being used by industry, government, and academia to understand how different diseases, medicines, chemicals and foods affect human health. The system offers researchers a new standard for predicting human response - with greater precision and control than today's cell culture or animal-based experimental methods. We are also leading a bold, new precision medicine initiative with our clinical partners. Named "Patient-on-a-Chip," the program is developing personalized chips with patients' own cells. This initiative will help transform the way each of us understands our own bodies and manages our own health. Research conducted using our Organ-Chips has been published in high-impact scientific journals, including Science. In addition, Organ-Chips have been acquired by the Museum of Modern Art (MoMA) in New York for their permanent collection, and have also been awarded Product Design of the Year 2015 by London's Design Museum. Our founding team pioneered the original Organs-on-Chips technology during their residency within the Wyss Institute for Biologically Inspired Engineering at Harvard University.
keywords:Biotechnology,Healthcare,Pharmaceuticals
$224.3M
Total Funding
168
Number of Employees
$32.5M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Emulate News
The new United manager is being backed to follow in the footsteps of some Ajax legends ahead of his arrival at Old Trafford.
PS Now and the new PS Plus won't allow PS3 games to be downloaded, only streamed. We dig into why.
Tears of wine is a phenomenon frequently observed as a ring of wine formed near the top of the glass generates droplets that fall back into...
Emulate, Inc., a leading provider of next generation in vitro models, today announced the close of an $82 million Series E financing round led by existing investor Northpond Ventures with additional participation from Perceptive Advisors. With this investment, Emulate has raised nearly $225 mill ...
Emulate, Inc., a Boston, MA-based provider of next generation in vitro models, closed an $82m Series E financing round. The round, which brought total funding raised to date to nearly $225m, was led by existing investor Northpond Ventures with participation from Perceptive Advisors. The compan ...
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $27.1M | 168 | -20% | $106.9M |
#2 | $18.8M | 168 | -1% | N/A |
#3 | $41.9M | 168 | 6% | N/A |
#4 | $18.8M | 168 | 5% | N/A |
#5 | $25.9M | 168 | -2% | $193.6M |
Emulate Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2014-07-29 | $12.0M | A | NanoDimension | Article |
| 2016-03-29 | $28.0M | B | OS Fund | Article |
| 2016-10-21 | $17.0M | B | Multiple | Article |
| 2018-06-20 | $36.0M | c | Founders Fund | Article |